PitchSend

Nuvectis Pharma Investor Presentation Deck

Financial and NVCT Stock Highlights Cash Runway into 1H2025 Ticker IPO Cash NuvectisPharma, Inc. Financials NVCT February 2022 $22.1M as of 09/30/2023 Insider Ownership Founders and >5% holders Research Coverage XH.C.WAINWRIGHT&CO. LADEN BURG THAL MANN ESTABLISHED 1876 T ROTH MKM 66% Joe Pantginis Aydin Huseynov Jonathan Aschoff 23

View entire presentation